Getein Biotech, Inc financials at a glance

+ Portfolio

The revenue of Getein Biotech, Inc is reported as 1.12334 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.48 Yuan Renminbi per share in 2023, which was 0 higher than 2020. And about -0.25813 billion Yuan Renminbi are reported as free cash flow in the financials of Getein Biotech, Inc 2023. Dividends of 0.18 Yuan Renminbi per share were paid to shareholders of Getein Biotech, Inc stock SHSE:603387 in fiscal 2023.

¥1.12B

Revenue

¥0.48

Earnings Per Share

67.42%

Gross Margin %

¥0.00M

Free Cash Flow

Revenue

1,123.34

Earnings Per Share

0.48

Gross Margin %

67.42

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2020	2016
Rev.	Revenue	N/A	¥1.12B	¥1.12B	¥0.00M
GM %	Gross Margin %	61.36%	67.42%	63.11%	0.00%
OM	Operating Margin	11.97%	19.59%	27.37%	0.00%
EPS	Earnings Per Share	¥0.50	¥0.48	¥0.48	¥0.34
Div.	Dividends	N/A	¥0.18	¥0.18	¥0.00
PR %	Payout Ratio %	0	37.50%	37.50%	0
Sha.	Shares	N/AM	507.57M	507.21M	380.32M
OCF	Operating Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M
FCF	Free Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M
FCFS	Free Cash Flow Per Share	¥0.25	¥0.15	¥0.20	¥0.00

Getein Biotech, Inc financials at a glance

Financials

Discover